Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
Breast Cancer: Targets and Therapy · 2023-08 · Volume 15 · 647-658
DOI: 10.2147/bctt.s426121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2023-08. Verfasst von Ling Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Human Reproductive and Genetic Center, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Human Reproductive and Genetic Center, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China.
- Department of Breast Surgery, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China.
ORCID-Profile: Xiangling Yu, Shan Wang
Zitieren
APA
Tong, L., Yu, X., Wang, S., Chen, L., & Wu, Y. (2023). Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer. Breast Cancer: Targets and Therapy, Volume 15, 647-658. https://doi.org/10.2147/bctt.s426121
Vancouver
Tong L, Yu X, Wang S, Chen L, Wu Y. Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer. Breast Cancer: Targets and Therapy. 2023;Volume 15:647-658. doi:10.2147/bctt.s426121
BibTeX
@article{Tong2023,
author = {Tong, Ling and Yu, Xiangling and Wang, Shan and Chen, Ling and Wu, Yibo},
title = {Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer},
journal = {Breast Cancer: Targets and Therapy},
year = {2023},
volume = {Volume 15},
pages = {647--658},
doi = {10.2147/bctt.s426121}
}
EUVIMED